Does CARMUSTINE Cause Malignant transformation? 88 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 88 reports of Malignant transformation have been filed in association with CARMUSTINE (carmustine). This represents 2.6% of all adverse event reports for CARMUSTINE.
88
Reports of Malignant transformation with CARMUSTINE
2.6%
of all CARMUSTINE reports
58
Deaths
0
Hospitalizations
How Dangerous Is Malignant transformation From CARMUSTINE?
Of the 88 reports, 58 (65.9%) resulted in death.
Is Malignant transformation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARMUSTINE. However, 88 reports have been filed with the FAERS database.
What Other Side Effects Does CARMUSTINE Cause?
Off label use (454)
Febrile neutropenia (297)
Myelodysplastic syndrome (295)
Disease progression (241)
Acute myeloid leukaemia (180)
Thrombocytopenia (174)
Pyrexia (152)
Drug ineffective (149)
Mucosal inflammation (148)
Second primary malignancy (141)
What Other Drugs Cause Malignant transformation?
OSIMERTINIB (109)
ETOPOSIDE (108)
MELPHALAN (95)
CYTARABINE (91)
CYCLOPHOSPHAMIDE (73)
PREDNISONE (69)
GEFITINIB (67)
VINCRISTINE (66)
DOXORUBICIN (61)
IFOSFAMIDE (60)
Which CARMUSTINE Alternatives Have Lower Malignant transformation Risk?
CARMUSTINE vs CARTEOLOL
CARMUSTINE vs CARVEDILOL
CARMUSTINE vs CASIMERSEN
CARMUSTINE vs CASIRIVIMAB
CARMUSTINE vs CASIRIVIMAB\IMDEVIMAB